A Long-term, Open-label, Non-comparative Study to Evaluate the Safety and Efficacy of a Modigraf Based Immunosuppression Regimen in Paediatric Solid Allograft Recipients
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 30 Sep 2017
At a glance
- Drugs Tacrolimus (Primary)
- Indications Allotransplant rejection; Heart transplant rejection; Liver transplant rejection; Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Acronyms PROGRESSION
- Sponsors Astellas Pharma
- 26 Jul 2017 Planned End Date changed from 1 Jul 2020 to 1 Mar 2021.
- 26 Jul 2017 Planned primary completion date changed from 1 Jul 2020 to 1 Mar 2021.
- 02 Oct 2015 Planned number of patients changed from 60 to 48, as reported by ClinicalTrials.gov.